...
首页> 外文期刊>European Heart Journal - Case Reports >The successful use of the Impella RP after a long cardiopulmonary resuscitation and systemic thrombolytic therapy in a patient with a fulminant pulmonary embolism: the first case report
【24h】

The successful use of the Impella RP after a long cardiopulmonary resuscitation and systemic thrombolytic therapy in a patient with a fulminant pulmonary embolism: the first case report

机译:经过长时间的心肺复苏和全身溶栓治疗,暴发性肺栓塞患者成功使用Impella RP:第一例报告

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Acute massive pulmonary embolism (PE) can result in progressive cardiogenic shock, right heart failure, and respiratory failure requiring cardiopulmonary resuscitation (CPR). We report the case of a 56-year-old woman who required prolonged CPR secondary to a highly suspected massive PE and cardiogenic shock. After receiving preclinical thrombolytic therapy, the patient was transferred to the intensive care unit with ongoing CPR. Because of persistent haemodynamic instability and acute right ventricular failure, an Impella RP was successfully implanted and immediate haemodynamic improvement was observed. Absent any contraindications, the Impella RP should be considered a feasible alternative in patients with acute right ventricular failure due to pulmonary embolism.
机译:急性大量肺栓塞(PE)会导致进行性心源性休克,右心衰竭和需要进行心肺复苏(CPR)的呼吸衰竭。我们报道了一名56岁女性的案例,该女性由于高度怀疑的大量PE和心源性休克而需要继发CPR。在接受临床前溶栓治疗后,患者被转移到重症监护病房,并进行了持续的心肺复苏。由于持续的血流动力学不稳定和急性右心室衰竭,成功植入了Impella RP并观察到立即的血流动力学改善。在没有任何禁忌症的情况下,对于因肺栓塞而导致的急性右心衰竭的患者,应考虑使用Impella RP。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号